Vote for your favorite mineral in #MinCup25! - Cuprosklodowskite vs. Ikaite
It's radioactive #cuprosklodowskite vs ephemeral #ikaite for today's match.
Log InRegister
Quick Links : The Mindat ManualThe Rock H. Currier Digital LibraryMindat Newsletter [Free Download]
Home PageAbout MindatThe Mindat ManualHistory of MindatCopyright StatusWho We AreContact UsAdvertise on Mindat
Donate to MindatCorporate SponsorshipSponsor a PageSponsored PagesMindat AdvertisersAdvertise on Mindat
Learning CenterWhat is a mineral?The most common minerals on earthInformation for EducatorsMindat ArticlesThe ElementsThe Rock H. Currier Digital LibraryGeologic Time
Minerals by PropertiesMinerals by ChemistryAdvanced Locality SearchRandom MineralRandom LocalitySearch by minIDLocalities Near MeSearch ArticlesSearch GlossaryMore Search Options
Search For:
Mineral Name:
Locality Name:
Keyword(s):
 
The Mindat ManualAdd a New PhotoRate PhotosLocality Edit ReportCoordinate Completion ReportAdd Glossary Item
Mining CompaniesStatisticsUsersMineral MuseumsClubs & OrganizationsMineral Shows & EventsThe Mindat DirectoryDevice SettingsThe Mineral Quiz
Photo SearchPhoto GalleriesSearch by ColorNew Photos TodayNew Photos YesterdayMembers' Photo GalleriesPast Photo of the Day GalleryPhotography

(2018) A targeting theranostics nanomedicine as an alternative approach for hyperthermia perfusion. Biomaterials, 183. 268-279 doi:10.1016/j.biomaterials.2018.04.016

Advanced
   -   Only viewable:
Reference TypeJournal (article/letter/editorial)
TitleA targeting theranostics nanomedicine as an alternative approach for hyperthermia perfusion
JournalBiomaterials
Year2018 (November)Volume183
PublisherElsevier BV
DOIdoi:10.1016/j.biomaterials.2018.04.016Search in ResearchGate
Generate Citation Formats
Mindat Ref. ID13472016Long-form Identifiermindat:1:5:13472016:8
GUID0
Full Reference(2018) A targeting theranostics nanomedicine as an alternative approach for hyperthermia perfusion. Biomaterials, 183. 268-279 doi:10.1016/j.biomaterials.2018.04.016
Plain Text(2018) A targeting theranostics nanomedicine as an alternative approach for hyperthermia perfusion. Biomaterials, 183. 268-279 doi:10.1016/j.biomaterials.2018.04.016
In(2018) Biomaterials Vol. 183. Elsevier BV

See Also

These are possibly similar items as determined by title/reference text matching only.

(2017) Tri-stimuli-responsive biodegradable theranostics for mild hyperthermia enhanced chemotherapy. Biomaterials, 126. 39-48 doi:10.1016/j.biomaterials.2017.02.025
(2015) Targeting glucose uptake with siRNA-based nanomedicine for cancer therapy. Biomaterials, 51. 1-11 doi:10.1016/j.biomaterials.2015.01.068
(2017) A strategy for actualization of active targeting nanomedicine practically functioning in a living body. Biomaterials, 141. 136-148 doi:10.1016/j.biomaterials.2017.06.037
(2018) An engineered, quantifiable in vitro model for analysing the effect of proteostasis-targeting drugs on tissue physical properties. Biomaterials, 183. 102-113 doi:10.1016/j.biomaterials.2018.08.041
(2018) Physical oncology: New targets for nanomedicine. Biomaterials, 150. 87-99 doi:10.1016/j.biomaterials.2017.10.014
(2017) Dextran sulfate nanoparticles as a theranostic nanomedicine for rheumatoid arthritis. Biomaterials, 131. 15-26 doi:10.1016/j.biomaterials.2017.03.044
(2018) Biomaterial scaffolds for non-invasive focal hyperthermia as a potential tool to ablate metastatic cancer cells. Biomaterials, 166. 27-37 doi:10.1016/j.biomaterials.2018.02.048
(2018) Double-sided effect of tumor microenvironment on platelets targeting nanoparticles. Biomaterials, 183. 258-267 doi:10.1016/j.biomaterials.2018.07.005
(2018) pH-sensitive radiolabeled and superfluorinated ultra-small palladium nanosheet as a high-performance multimodal platform for tumor theranostics. Biomaterials, 179. 134-143 doi:10.1016/j.biomaterials.2018.06.040
(2016) Targeting dendritic cells in lymph node with an antigen peptide-based nanovaccine for cancer immunotherapy. Biomaterials, 98. 171-183 doi:10.1016/j.biomaterials.2016.05.008
(2016) Integrated self-assembling drug delivery system possessing dual responsive and active targeting for orthotopic ovarian cancer theranostics. Biomaterials, 90. 12-26 doi:10.1016/j.biomaterials.2016.03.005
 
and/or  
Mindat.org is an outreach project of the Hudson Institute of Mineralogy, a 501(c)(3) not-for-profit organization.
Copyright © mindat.org and the Hudson Institute of Mineralogy 1993-2025, except where stated. Most political location boundaries are Β© OpenStreetMap contributors. Mindat.org relies on the contributions of thousands of members and supporters. Founded in 2000 by Jolyon Ralph.
To cite: Ralph, J., Von Bargen, D., Martynov, P., Zhang, J., Que, X., Prabhu, A., Morrison, S. M., Li, W., Chen, W., & Ma, X. (2025). Mindat.org: The open access mineralogy database to accelerate data-intensive geoscience research. American Mineralogist, 110(6), 833–844. doi:10.2138/am-2024-9486.
Privacy Policy - Terms & Conditions - Contact Us / DMCA issues - Report a bug/vulnerability Current server date and time: September 14, 2025 13:51:59
Go to top of page